Which type of patients are particularly at risk for developing aspergillosis?

Immunocompromised patients, such as those undergoing chemotherapy, are particularly at risk for developing aspergillosis due to their weakened immune systems. Aspergillus species, which are molds commonly found in the environment, can cause serious infections in individuals whose immune responses are compromised. This includes patients undergoing treatments that suppress immune function, such as chemotherapy or high-dose corticosteroids, as well as those with certain underlying health conditions like HIV/AIDS, organ transplants, or severe malnutrition.

In contrast, healthy individuals typically have robust immune systems capable of defending against this type of fungal infection. While patients with diabetes and aged individuals can also face increased risks for various infections, the specific susceptibility to aspergillosis predominantly affects those who are immunosuppressed. Therefore, understanding the patient population that is most vulnerable to such infections is crucial for prevention and treatment strategies in clinical settings.